SCHEMBL4560407

SCHEMBL4560407

Cc1cc(Nc2ncnc3ccc(Br)cc23)ccc1OCc1ccccn1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.76
ERBB2 P04626 9/20 0.76
LCK P06239 1/20 0.60
MAPK1 P28482 2/20 0.55
ALK Q9UM73 1/20 0.52
ERBB3 P21860 1/20 0.51
ERBB4 Q15303 1/20 0.51
MAPT P10636 2/20 0.50
AURKA O14965 1/20 0.50
RPS6KB1 P23443 1/20 0.50
ABCG2 Q9UNQ0 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GAK O14976 1/20 0.49
MAPK13 O15264 1/20 0.49
ABL1 P00519 1/20 0.49
CYP1A2 P05177 1/20 0.49
CDK1 P06493 1/20 0.49
CYP3A4 P08684 1/20 0.49
FBP1 P09467 1/20 0.49
CYP2D6 P10635 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6185804 0.99 EGFR (0.75) EGFRERBB2LCKMAPK1ALK
SCHEMBL8307102 0.90 EGFR (0.76) EGFRERBB2LCKALKERBB3
SCHEMBL8309272 0.90 EGFR (0.76) EGFRERBB2LCKERBB3ERBB4
SCHEMBL17845956 0.88 ERBB2 (0.73) EGFRERBB2LCKERBB3ERBB4
SCHEMBL30125866 0.88 ERBB2 (0.73) EGFRERBB2LCKERBB3ERBB4
Hydrochloric Acid SCHEMBL29793455 0.87 ERBB2 (0.72) EGFRERBB2LCKERBB3ERBB4
Hydrochloric Acid SCHEMBL17845945 0.87 ERBB2 (0.72) EGFRERBB2LCKERBB3ERBB4
SCHEMBL8306136 0.87 EGFR (0.69) EGFRERBB2LCKERBB3ERBB4
SCHEMBL8306859 0.87 EGFR (1.00) EGFRERBB2LCKALKERBB4
Hydrochloric Acid SCHEMBL8309362 0.86 EGFR (0.98) EGFRERBB2LCKALKERBB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009070328-A1 MODULATORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY FOR USE IN THE TREATMENT OR PREVENTION OF SUBSTANCE ABUSE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-06-04 WO disclosed
EP-0790986-B1 ANILINE DERIVATIVES ZENECA LTD (GB) 1999-01-20 EP disclosed
EP-0880507-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
US-5821246-A USEFUL AS TYROSINE KINASE INHIBITORS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES SUCH AS CANCER ZENECA LIMITED (GB) 1998-10-13 US disclosed
EP-0790986-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1997-08-27 EP disclosed
WO-1997030034-A1 QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS ZENECA LIMITED (GB) 1997-08-21 WO disclosed
WO-1996015118-A1 ANILINE DERIVATIVES ZENECA LIMITED (GB) 1996-05-23 WO disclosed